Welcome to Sussex Health Outcomes
Research & Education in Cancer

Research PublicationsContact Us

The central aim of Sussex Health Outcomes, Research & Education in Cancer (SHORE-C) is to conduct pragmatic research in psychosocial oncology.

Our work includes:

  1. Measuring Quality of Life (QoL) in clinical trials of cancer therapy

  2. Designing Patient Reported Outcome (PRO) measures

  3. Developing and evaluating interventions to help patients deal with treatment side-effects

  4. Producing educational materials and helping to improve communication skills of Cancer Healthcare Professionals

^ Top


Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefits. Read morered arrow

Ovarian Cancer in Nature Reviews Disease Primers (restricted access) Read morered arrow

No man’s land: information needs and resources of men with metastatic castrate resistant prostate cancer. Read morered arrow

Patient-reported outcomes in metastatic castrate-resistant prostate cancer.
Read morered arrow

Essay 4. Patient-reported outcome measures and the evaluation of services in Challenges, solutions and future directions in the evaluation of service innovations in health care and public health.
Read morered arrow

Questioning assent: how are children's views included as families make decisions about clinical trials?
Read morered arrow

A feasibility study exploring the role of pre-operative assessment when examining the mechanism of 'chemo-brain' in breast cancer patients.
Read morered arrow

Stress levels amongst nurses caring for women with breast cancer: results from a survey of nurses on the south east coast.
Read morered arrow

Patient-reported outcome measures for cancer caregivers: a systematic review.
Read morered arrow

Second international consensus guidelines for breast cancer in young women (BCY2).
Read morered arrow

Reply to P.F. Pinsky, C.P. Crum, and M.W. McIntosh et al.
Read more
red arrow

Overtreatment of Low-Grade Ductal Carcinoma In Situ.
Read more
red arrow

^ Top



NEW Pilot Workshops

Talking with Patients about Metastatic Bone Disease (MBD)
Facilitator: Professor Dame Lesley Fallowfield

Monday September 19th (12.30pm to 5.30pm) – Prostate Cancer
Tuesday September 20th (9am to 1pm) – Breast Cancer
Venue to be confirmed: RNLI College West Quay Road, Poole BH15 1HZ

The pilot workshop is aimed at clinicians and nurses treating and caring for breast and/or prostate cancer patients with Metastatic Bone Disease (MBD). Participants can attend one or both half days (CMEs applied for).

The workshop uses a set of 5 newly created educational videos illustrating different MBD consultations. The scenarios do not show the “right” or “wrong” way to discuss MBD but are used as “triggers” to engage participants in discussion. The groups are small with a maximum of 10 delegates and facilitated by Professor Dame Lesley Fallowfield.

Attendance is free as the course costs are covered by charitable funds but travel expenses cannot be reimbursed.

Places are limited so for more information, or, to register please email adminshore-c@sussex.ac.uk




More news ...

^ Top